[ad_1]
[앵커]
YTN explores and reports on suspicions and controversies regarding Korea’s world’s first stem cell treatment four days from today. In 2011, the Lee Myung-bak administration approved the use of a stem cell treatment for acute myocardial infarction called ‘AMI of the heartgram’. However, the manufacturer was suspected of having frozen the patients’ stem cells without even obtaining permission while undergoing the treatment. Reporter Kim Woong-rae from the Exploration and Planning Team reports. Hearti Cellgram AMI. It is the first stem cell treatment for acute myocardial infarction in the world to be marketed with the approval of the product 9 years ago. HeartiCelgram AMI is made from mesenchymal stem cells obtained from the bone marrow of a patient with acute myocardial infarction. The product was approved by the Ministry of Food and Drug Safety based on the fact that when administered to the heart, it partially restores the heart’s ability to pump blood throughout the body. However, suspicions arose that the manufacturer, Phamicel, created a treatment by freezing and melting stem cells, contrary to the license. This is a patient management record obtained by YTN. It was written by a salesperson, and there are a lot of patients who took a remedy several years after freezing, the so-called “stem cell bank.” Some of the patients who went directly to the hospital without going through a vendor were also recommended to be frozen and administered. Famicel said it was simply frozen bone marrow blood, which was only part of the manufacturing process. This explains that there is no problem because it was a minimal operation that did not require a permit under the corresponding law. However, the results were different. First of all, even if the cells are simply frozen, in a medical institution, a doctor should. This means that if you leave a medical institution, you must obtain permission for the slightest manipulation, as specified in the regulation related to the Law on Pharmaceutical Affairs, and the Ministry of Food and Drug Safety has disclosed this several times. Looking at the promotional video for Pamicel in the past, it is questionable if the stem cells were frozen, not the blood from the bone marrow. Considering the fact that it takes about a week to obtain stem cells by culturing mononuclear cells isolated from the blood of the bone marrow, it can be suspected that the stem cells are frozen rather than simply collecting blood from the bone marrow. . I was able to hear more details from the former Phamicel Stem Cell Lab staff. When I thawed the bone marrow of a bank customer to make HeartiCellgram, some defects came out where the stem cells were not cultured, and because of this, the stem cells were cultured and then frozen to see if they could be manufactured and sold as a treatment. In the HeartiCelgram manufacturing process, it seems necessary to investigate whether an unauthorized freezing of stem cells was actually performed. This is because the safety and efficacy of the world’s first stem cell treatment cannot be guaranteed. This is YTN Kim Woong-rae.